From The Hill
FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
The Food and Drug Administration (FDA) on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with t...